100 related articles for article (PubMed ID: 11014890)
1. Expression of wild-type p53 and Bcl-2 family genes oscillates with recurrent remission and relapse in an unusual case of low-grade lymphoma.
Aizman I; Many A; Peller S; Ramot B; Kaufmann Y
Acta Haematol; 2000; 103(4):177-85. PubMed ID: 11014890
[TBL] [Abstract][Full Text] [Related]
2. Effect of Cx43 gene-modified leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro.
Zhang X; Liu Y; Si YJ; Chen XH; Li ZJ; Gao L; Gao L; Zhang C
Leuk Res; 2012 Feb; 36(2):198-204. PubMed ID: 22030334
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins.
Nita ME; Nagawa H; Tominaga O; Tsuno N; Fujii S; Sasaki S; Fu CG; Takenoue T; Tsuruo T; Muto T
Br J Cancer; 1998 Oct; 78(8):986-92. PubMed ID: 9792140
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia.
Srinivas G; Kusumakumary P; Nair MK; Panicker KR; Pillai MR
J Cancer Res Clin Oncol; 2000 Jan; 126(1):62-7. PubMed ID: 10641752
[TBL] [Abstract][Full Text] [Related]
5. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia.
Findley HW; Gu L; Yeager AM; Zhou M
Blood; 1997 Apr; 89(8):2986-93. PubMed ID: 9108419
[TBL] [Abstract][Full Text] [Related]
7. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
[TBL] [Abstract][Full Text] [Related]
8. High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53.
Soini Y; Raunio H; Pääkkö P
Tumour Biol; 1998; 19(3):176-85. PubMed ID: 9591044
[TBL] [Abstract][Full Text] [Related]
9. p53, bcl-2 and bax abnormalities in non-Hodgkin's lymphomas of the head and neck.
Miyauchi M; Higashikawa K; Sugiyama M; Harada T; Sasaki N; Ishikawa T
J Oral Pathol Med; 2000 Apr; 29(4):180-5. PubMed ID: 10766396
[TBL] [Abstract][Full Text] [Related]
10. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.
Violette S; Poulain L; Dussaulx E; Pepin D; Faussat AM; Chambaz J; Lacorte JM; Staedel C; Lesuffleur T
Int J Cancer; 2002 Apr; 98(4):498-504. PubMed ID: 11920608
[TBL] [Abstract][Full Text] [Related]
11. Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low-grade lymphoma.
Kaufmann Y; Amariglio N; Rosenthal E; Hirsch YJ; Many A; Rechavi G
J Immunol; 2005 Nov; 175(10):6940-7. PubMed ID: 16272354
[TBL] [Abstract][Full Text] [Related]
12. Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, Bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridol.
Pepper C; Thomas A; Hoy T; Tighe J; Culligan D; Fegan C; Bentley P
Cell Cycle; 2003; 2(1):53-8. PubMed ID: 12695689
[TBL] [Abstract][Full Text] [Related]
13. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
14. Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo.
Prokop A; Wieder T; Sturm I; Essmann F; Seeger K; Wuchter C; Ludwig WD; Henze G; Dörken B; Daniel PT
Leukemia; 2000 Sep; 14(9):1606-13. PubMed ID: 10995007
[TBL] [Abstract][Full Text] [Related]
15. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
Schmitt E; Steyaert A; Cimoli G; Bertrand R
Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
[TBL] [Abstract][Full Text] [Related]
16. Activation of multidomain and BH3-only pro-apoptotic Bcl-2 family members in p53-defective cells.
Paquet C; Schmitt E; Beauchemin M; Bertrand R
Apoptosis; 2004 Nov; 9(6):815-31. PubMed ID: 15505424
[TBL] [Abstract][Full Text] [Related]
17. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
Luke JJ; Van De Wetering CI; Knudson CM
Cell Death Differ; 2003 Jun; 10(6):740-8. PubMed ID: 12761582
[TBL] [Abstract][Full Text] [Related]
18. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
